secwatch.observer — SEC 8-K summary
======================================

Issuer:     InspireMD, Inc. (NSPR)
CIK:        0001433607
Form:       8-K
Filed at:   2025-07-31T23:59:59+00:00
Accession:  0001641172-25-021675
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 3.02, 5.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InspireMD raises $58M via PIPE and warrant exercise; appoints Ray Cohen to board
--------------------------------------------------------------------------------

- PIPE gross proceeds $40.1M: 16.6M shares/pre-funded warrants at $2.42/share; led by OrbiMed and Marshall Wace.
- Warrant exercise yields $17.9M: 12.9M Series I warrants exercised at $1.3827, triggered by FDA PMA of CGuard Prime.
- Combined $58M to fund U.S. commercial launch of CGuard Prime; intended use includes sales/marketing, R&D, working capital.
- Raymond W. Cohen appointed to Board (Cl. 3), effective Aug 1; former CEO of Axonics (sold to BSX for $3.7B), brings MedTech scaling expertise.
- Directors Kathryn Arnold and Thomas Kester will not stand for reelection in 2026; expected resignations by Dec 31, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1433607/000164117225021675/0001641172-25-021675-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1433607/000164117225021675/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-021675

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer